NovoLog Mix 70/30

Product NDC: 50090-4074
Requested package NDC: 50090-4074-0
11-digit product format: 500904074
Labeler code: 50090
Product ID: 50090-4074_1efe8a76-4799-4e9f-b686-543071d912ea
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: insulin aspart
Dosage form: INJECTION, SUSPENSION
Route: SUBCUTANEOUS
Labeler: A-S Medication Solutions
Application: BLA021172
Marketing category: BLA
Marketing start: 2001-11-01
Marketing end: 0000-00-00
Substance: INSULIN ASPART
Active strength: 100 [iU]/mL
Pharmacologic classes: Insulin Analog [EPC], Insulin [CS]
NDC exclude flag: No
Listing certified through: 2023-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 1 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded package	package	50090-4074	50090-4074-0	D	Discontinued by firm		2026-08-17

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 9 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Snapshot, Source SHA-256 table
Captured / source date	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	`0efc9e666f02…`	`f202fb6c5f17…`

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
50090-4074-0	ML - Milliliter	50090-4074	ac90af5e-65e1-4ff1-a814-dee4b848dc9c	1	2024-05-16

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 6 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
NovoLog Mix 70/30	INSULIN ASPART	REMEDYREPACK INC.	66da64f7-ca50-47d2-95fa-de37005eef85	2026-05-18	Warnings, Adverse reactions	Exact identifier application number: BLA021172
Insulin Aspart Protamine and Insulin Aspart Mix 70/30	INSULIN ASPART	REMEDYREPACK INC.	5d9f0e10-edb9-4960-bd62-cf406e75bbe7	2026-04-07	Warnings, Adverse reactions	Exact identifier application number: BLA021172
NovoLog Mix 70/30	INSULIN ASPART	A-S Medication Solutions	19888a44-b330-462a-864d-338c5893dd63	2026-01-29	Warnings, Adverse reactions	Exact identifier application number: BLA021172
.Insulin Aspart Protamine and Insulin Aspart	INSULIN ASPART	A-S Medication Solutions	14499781-b90e-47d5-a7de-006965439b94	2024-02-22	Warnings, Adverse reactions	Exact identifier application number: BLA021172
Insulin Aspart Protamine and Insulin Aspart Mix 70/30	INSULIN ASPART	Novo Nordisk Pharma, Inc.	fc94baa4-3606-48bc-a781-9617ab6960ef	2023-02-28	Warnings, Adverse reactions	Exact identifier application number: BLA021172
NovoLog Mix 70/30	INSULIN ASPART	Novo Nordisk	1861fcee-7673-4afe-a206-08fa05c0add2	2023-02-28	Warnings, Adverse reactions	Exact identifier application number: BLA021172

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLA	Proprietary name	Proper name	License type	Status	Latest source
021172	Novolog Mix 70/30	insulin aspart protamine and insulin aspart	351(a)	Rx	2026-07-01

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
D933668QVX	INSULIN ASPART	116094-23-6	INSULIN ASPART

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Marketing start	Marketing end	Sample	Exclude flag	Status
50090-4074-0	50090407400	1 VIAL, GLASS in 1 CARTON (50090-4074-0) > 10 mL in 1 VIAL, GLASS	2019-01-21	0000-00-00	No	No	Current